Consistent with this possibility, OCI-LY10 tumor lysates from mice subjected to oral gavage with voruciclib (as described previously in Fig. 2d), exhibited elevated levels of BCL-xL compared to vehicle controls as determined by Western blot analysis (Figs 5a and S8). This evidence concerns the gene BCL2L1 and neoplasm.